CRESUD INC (CRESY): Financial results for Q1 2027

CRESUD INC (CRESY) furnished an SEC Form 6-K — earnings release. Yes o No x CRESUD S.A.C.I.F. and A. (THE “COMPANY”) REPORT ON FORM 6-K Attached is the English translation of the letter filed with the Comision Nacional de Valores and Bolsa de Comercio de Buenos Aires on November 9, 2026. By letter dated November 9, 2026, the company reported t

Original reporting
Published Nov 9, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CRESY
Bearish
high confidence
Mentioned
$CRESY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$CRESYBearishMed
01

Why it matters

The earnings miss is likely to trigger a sell‑off in the ADR, though the dividend and Brazil land sale may cushion the impact.

02

Market read

Primary earnings release for a mid‑cap emerging‑market ADR; relevance mainly to investors in CRESY and sector peers.

03

What to watch

The company announced a dividend and a sizable land sale in Brazil, which could provide near‑term cash support.

Relevance 7/10Novelty 8/10Timing: same‑day release

Background

CRESUD Sociedad Anónima (CRESY) filed a Form 6‑K reporting its Q1 2027 financial results, including a sharp profit decline and a dividend declaration.

Company-level read

Ticker impact

$CRESYBearishHigh confidence
Context

Q1 2027 earnings show net income fell to ARS 26.3bn from ARS 146.9bn a year earlier, a sharp decline driven by fair‑value losses on investment properties.

Expected impact

downward pressure as investors price in the profit decline

Evidence & confidence

The large drop in net income and negative comprehensive income signal weaker performance, prompting sell‑offs.

Market effects

Agricultural and urban real‑estate segments may see broader scrutiny after the earnings decline.

Argentina‑listed ADRs could face short‑term pressure.

Limited to investors with exposure to emerging‑market agribusiness and real‑estate stocks.

Counterpoint

If the decline is viewed as a one‑off fair‑value adjustment, the stock could rebound on the back of higher adjusted EBITDA.

Key entities

  • CRESUD Sociedad Anónima

    Argentinian agribusiness and real‑estate conglomerate listed in the US as CRESY.

  • Eduardo Sergio Elsztain

    Principal shareholder holding ~39% of CRESY.

Related articles

$CRESYMed

CRESUD INC (CRESY): Financial results for FY2026

CRESUD INC (CRESY) furnished an SEC Form 6-K — earnings release. Yes o No x CRESUD S.A.C.I.F. and A. (THE “COMPANY”) REPORT ON FORM 6-K Attached is the English translation of the letter filed with the Comision Nacional de Valores and Bolsas y Mercados Argentinos S.A. on September 7, 2026. By letter dated September 7, 2026, the company reported

$TDGMedAI 8/10

TransDigm (TDG) Q4 2026 Earnings Call Transcript

TransDigm (TDG) reported Q4 2026 earnings, highlighting double-digit growth in all major end markets. Revenue and EBITDA exceeded guidance, with defense delivering three consecutive quarters of double-digit growth. The company repurchased $940 million in stock, totaling $2.75 billion for the year. TransDigm deployed $7 billion in M&A and share repurchases, acquiring several companies.

$DDOGHighAI 9/10

“Missing Forest-for-the-Trees”: Datadog Sinks 17% in a Week as Its Biggest AI Customer Cuts Back

Datadog (DDOG) stock fell 17% in a week after reporting 35% Q3 revenue growth to $1.2B but guiding Q4 revenue to $1.19-1.2B, roughly flat. The decline was driven by its largest AI customer reducing usage, though growth outside this customer is accelerating. Cloudflare (NET) reported strong Q3 results and a rising Q4 outlook, suggesting the slowdown may be isolated. Datadog trades at 60x forward earnings, below its usual multiple.

$NOVTHighAI 8/10

Novanta (NOVT) Q3 2026 Earnings Call Transcript

Novanta (NOVT) reported Q3 2026 revenue of $305M, up 23%, with organic growth of 10%. Adjusted EBITDA rose 38% to $80M, and adjusted EPS increased 21% to $1.05. The company acquired Riverpoint Medical, expanding its medical end markets to 53% of revenue. Customer bookings grew 29%, and backlog reached $543M. Operating cash flow tripled year-over-year to $156M. Novanta expects full-year 2027 gross margin expansion and strong earnings growth, driven by new products and acquisitions.